The Top Line

June 17, 2022


Listen Later

While revenue reflects how well a company’s products are selling, profit is the financial metric that really matters. It tells investors how efficiently a company is managed and how healthy the business is overall. We’ve taken a look at these bottom line figures and compiled a list of the top 10 most profitable pharma companies. But that's not all. The FDA advisory committee meeting met last Thursday and Friday, and the stakes were high. Bluebird bio came away on top. The committee endorsed two of its gene therapy candidates. Lastly, we’re all celebrating here at Fierce because our team’s faces are plastered on billboards at BIO International Convention. And we sent one shoe-leather reporter on a wild goose chase to find them. 

To learn more about the topics in this episode: 

  • The top 10 most profitable pharma companies in 2021
  • Pfizer already agreed to delay supply of COVID-19 shots to EU, now the bloc wants more
  • GSK hails phase 3 win for RSV vaccine in older adults, sparking race to regulators
  • Rune Labs translates Apple Watch data into Parkinson's insights with FDA nod
  • Bluebird gene therapy overcomes safety worries to snag a win at FDA advisory panel
  • Bluebird scores 2nd straight win at high-stakes FDA gene therapy meeting
  • Amid FDA delay, Amylyx scores conditional ALS drug nod in Canada
  • Eli Lilly's Olumiant snags biopharma's first FDA green light for alopecia areata
  • Alnylam's next-gen RNA drug Amvuttra wins FDA approval—and a Pfizer showdown may await
  • Ekso Bionics nabs FDA exoskeleton clearance for multiple sclerosis rehabilitation
  • Pfizer gives up on Paxlovid in less vulnerable COVID patients after data fail to impress
  • The Top Line is produced by senior multimedia producer Teresa Carey with editor-in-chief Tracy Staton, managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. 

    See omnystudio.com/listener for privacy information.

    ...more
    View all episodesView all episodes
    Download on the App Store

    The Top LineBy Fierce Life Sciences

    • 4
    • 4
    • 4
    • 4
    • 4

    4

    11 ratings


    More shows like The Top Line

    View all
    Planet Money by NPR

    Planet Money

    30,874 Listeners

    Motley Fool Money by The Motley Fool

    Motley Fool Money

    3,237 Listeners

    Exchanges by Goldman Sachs

    Exchanges

    965 Listeners

    Odd Lots by Bloomberg

    Odd Lots

    1,995 Listeners

    WSJ Tech News Briefing by The Wall Street Journal

    WSJ Tech News Briefing

    1,658 Listeners

    The a16z Show by Andreessen Horowitz

    The a16z Show

    1,094 Listeners

    The Readout Loud by STAT

    The Readout Loud

    336 Listeners

    Wall Street Breakfast by Seeking Alpha

    Wall Street Breakfast

    1,051 Listeners

    Behind the Money by Financial Times

    Behind the Money

    228 Listeners

    The Journal. by The Wall Street Journal & Spotify Studios

    The Journal.

    6,095 Listeners

    BioCentury This Week by BioCentury

    BioCentury This Week

    35 Listeners

    Economics Explained by Economics Explained

    Economics Explained

    150 Listeners

    Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

    Biotech Hangout

    21 Listeners

    The Markets by Goldman Sachs

    The Markets

    76 Listeners

    WSJ's Take On the Week by The Wall Street Journal

    WSJ's Take On the Week

    141 Listeners